Tesamorelin – (Lyophilized Powder) – For Research Use Only

Tesamorelin is a stabilized synthetic peptide analog of growth hormone-releasing hormone (GHRH 1–44) containing a trans-3-hexenoic acid modification at position 2. It binds GHRH receptors to enhance GH synthesis and secretion in experimental settings. Tesamorelin is used in endocrine and metabolic research to examine peptide stability, receptor binding kinetics, and somatotropic axis modulation.
In RUO settings, tesamorelin is applied in mechanistic studies of receptor-coupled signaling, endocrine feedback circuitry, and GH/IGF-axis–associated molecular readouts in controlled in-vitro assays and in-vivo animal models.

---

Product Details:

Peptide: Tesamorelin

Purity: >98%

Form: Lyophilized powder

Quantity: 10mg or 20mg per vial

Storage: Store lyophilized at -20°C. Reconstituted product should be refrigerated (2–8°C) and used within 30 days.

Grade: For research purposes only. Not for human consumption, therapeutic, or diagnostic use.

---

Potential Research Applications:

• GHRHR pharmacology: ligand binding, potency, and receptor-activation assays
• Second-messenger studies: adenylate cyclase/cAMP-linked signaling readouts and downstream transcriptional responses
• GH/IGF-axis pathway mapping in controlled in-vitro systems and in-vivo animal models
• Endocrine feedback and signaling kinetics experiments (including receptor desensitization concepts)
• Exploratory biomarker workflows in metabolic and neuroendocrine research models

For laboratory research only. This product is not intended to diagnose, treat, cure, or prevent any disease.